Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

1,463 recalls · Class I, newest first

Class I · High risk

Prolotherapy with Phenol

Non-Sterility: Hartley Medical Center Pharmacy, Inc. is recalling Prolotherapy with Phenol due to non-sterility concerns.

Terminated Sterility / contamination Hartley Medical Center Pharmacy, Incorporated D-1830-2015
Class I · High risk

Prolotherapy with Phenol

Non-Sterility: Hartley Medical Center Pharmacy, Inc. is recalling Prolotherapy with Phenol due to non-sterility concerns.

Terminated Sterility / contamination Hartley Medical Center Pharmacy, Incorporated D-1829-2015
Class I · High risk

LiDa DAIDAIHUA

Marketed Without An Approved NDA/ANDA: presence of undeclared Sibutramine and Phenolphthalein.

Terminated Chemical / undeclared Blue Square Market, Inc. D-0296-2016
Class I · High risk

fentaNYL Citrate

Subpotent Drug: confirmed subpotency in one lot of this product that was packaged and stored in syringes.

Terminated Wrong potency / content Pharmedium Services, LLC D-0093-2017
Class I · High risk

PYROLA Advanced Joint Formula capsules

Marketed Without An Approved NDA/ANDA: Product was found to contain undeclared diclofenac, a prescription non-steroidal anti-inflammatory drug, and chlorpheniramine, an over-the-counter antihistimine, making this an unapproved drug.

Terminated Chemical / undeclared GC Natural Nutrition, Inc. D-1330-2015
Class I · High risk

Morphine Sulfate

Sub-potent Drug; firm's analysis revealed subpotent result for morphine sulfate assay.

Terminated Wrong potency / content Pharmedium Services, LLC NDC 61553-401-44 D-0658-2016

Recalls by year